OTC Markets EXMKT - Delayed Quote USD

Nemaura Medical Inc. (NMRD)

0.0001
0.0000
(0.00%)
At close: May 14 at 4:00:00 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Dr. Dewan Fazlul Hoque Chowdhury Ph.D. Chairman, Interim CFO, CEO, President and Principal Financial & Accounting Officer 338.58k -- 1973
Mr. Jay L. Warner Head of U.S. Commercial Operations -- -- --
Mr. Thomas Bendix Mortensen Head of E.U. Commercial Operations & Marketing -- -- --
Ms. Samantha Sanders Global Head of Digital Programs -- -- --

Nemaura Medical Inc.

57 West 57th Street
Manhattan
New York, NY 10019
United States
646 416 8000 https://nemauramedical.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
36

Description

Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.

Corporate Governance

Nemaura Medical Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 15, 2025 at 12:30 PM UTC - May 23, 2025 at 12:30 PM UTC

Nemaura Medical Inc. Earnings Date

Recent Events

September 26, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

July 1, 2024 at 12:00 AM UTC

DEF 14C: Proxy Statements

May 17, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 22, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 19, 2024 at 12:00 AM UTC

PRE 14C: Proxy Statements

April 10, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

February 26, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

February 12, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

January 17, 2024 at 12:00 AM UTC

DEF 14A: Proxy Statements

January 3, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers